Skip to main content
Signal8

LifeMD Reports First Quarter 2026 Results

$LFMDPress releaseMay 6, 2026, 4:05 PM ET

LifeMD reported Q1 2026 revenue of $50.2 million, beating company guidance, while gross margin expanded 420 basis points to 88%. Operational momentum was strong, with record quarterly net subscriber adds of over 42,000 driven by a 120% sequential increase in weight management sign-ups and 657% growth in Women's Health.

Key figures

Revenue
$50.2 million
Guidance
FY26 revenue $220M-$230M, Adj EBITDA $12M-$17M; Q2 revenue $47M-$50M
Revenue Yoy
-1%
Cash
$34.5 million
Gross margin
88%
Adjusted ebitda
-$4.5 million
Active subscribers
365004

AI analysis

Red flags2 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.